Logotype for Aldeyra Therapeutics Inc

Aldeyra Therapeutics (ALDX) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Aldeyra Therapeutics Inc

Proxy filing summary

27 Apr, 2026

Voting matters and shareholder proposals

  • Election of one Class III Director, with Todd C. Brady, M.D., Ph.D. nominated for the position.

  • Ratification of BDO USA, P.C. as the independent registered public accounting firm for the year ending December 31, 2026.

  • Advisory vote to approve the compensation of named executive officers.

  • Additional business may be addressed if properly brought before the meeting or any adjournment.

Board of directors and corporate governance

  • Board recommends voting in favor of all proposals presented at the annual meeting.

Executive compensation and say-on-pay

  • Shareholders are asked to approve, on a non-binding advisory basis, the compensation of named executive officers.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more